| 5663 |
Centers for Disease Control and Prevention |
Html |
en |
o-Chlorostyrene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6554 |
Centers for Disease Control and Prevention |
Html |
en |
QuickStats: Percentage of Hospital Outpatient Department Visits in Which a Physician Assistant or Advance Practice Nurse* Was Seen - National Hospital Ambulatory Medical Care Survey, United States, 1999-2009 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.497749 |
| endorsement | 0.447378 |
| Alternate Text | 0.486206 |
| Human Services | 0.563373 |
| assistive technology | 0.501459 |
| U.S. Department | 0.557209 |
| MMWR HTML versions | 0.554344 |
| electronic PDF version | 0.5465 |
| percentage | 0.415898 |
| e-mail | 0.429732 |
| Contact GPO | 0.503128 |
| commercial sources | 0.485824 |
| hospital outpatient department | 0.716112 |
| National Hospital Ambulatory | 0.566964 |
| current prices | 0.481131 |
| nurse midwife | 0.547324 |
| original paper copy | 0.544786 |
| United States | 0.486949 |
| U.S. Government Printing | 0.54571 |
| Superintendent | 0.416214 |
| nurse practitioner | 0.54345 |
| assistance | 0.415658 |
| title | 0.414719 |
| percent | 0.416303 |
|
| MMWR readers | 0.489082 |
| character translation | 0.48051 |
| visits | 0.486524 |
| file | 0.415764 |
| MMWR paper copy | 0.550845 |
| physician present | 0.495436 |
| Persons | 0.415828 |
| format errors | 0.483564 |
| subject line | 0.491947 |
| Health | 0.426524 |
| advance practice nurse | 0.937725 |
| typeset documents | 0.486959 |
| trade names | 0.485902 |
| official text | 0.479239 |
| Estimates | 0.415099 |
| Medical Care Survey | 0.559333 |
| non-CDC sites | 0.484691 |
| physician assistant | 0.664805 |
| hospital outpatient departments | 0.580861 |
| report | 0.414706 |
| information | 0.415778 |
| Accommodation | 0.414732 |
| electronic conversions | 0.480153 |
| printable versions | 0.477485 |
|
CLICK HERE |
| 7004 |
Centers for Disease Control and Prevention |
Html |
en |
Section 3 of the Tobacco Control Act - Purpose |
null |
| et seq. | 0.408422 |
| effective oversight | 0.399259 |
| tobacco-related diseases | 0.392632 |
| U.S.C. | 0.319366 |
| adults | 0.315892 |
| Drug Administration | 0.690386 |
| young people | 0.400767 |
| disease risk | 0.386933 |
| distribution | 0.319195 |
| issues | 0.317892 |
| research | 0.32921 |
| illicit trade | 0.394329 |
| division | 0.319131 |
| national standards | 0.399147 |
| harmful components | 0.401029 |
| conjunction | 0.316876 |
| identity | 0.317439 |
| safety | 0.316158 |
| particular concern | 0.402098 |
| dependence | 0.321272 |
| ingredients | 0.31695 |
|
| Cosmetic Act | 0.407712 |
| tobacco product manufacturers | 0.576388 |
| dependency effects | 0.393063 |
| tar | 0.318775 |
| public disclosure | 0.399102 |
| flexible enforcement authority | 0.496265 |
| appropriate regulatory controls | 0.45767 |
| public health officials | 0.476151 |
| Federal Food | 0.403781 |
| respect | 0.320015 |
| tobacco industry | 0.573726 |
| tobacco products | 0.979723 |
| marketing | 0.319216 |
| sale | 0.315924 |
| Federal regulatory authority | 0.515324 |
| future | 0.316222 |
| social costs | 0.385155 |
| cessation | 0.317749 |
| purchasers | 0.320228 |
| harmful tobacco products | 0.596546 |
|
CLICK HERE |
| 8903 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - About Malaria - FAQs |
Frequently asked questions about malaria, disease, transmission, symptoms, diagnosis, treatment, complications with pregnancy, prevention, eradication and endemic areas. |
| red blood cells | 0.390702 |
| malaria medicines | 0.494516 |
| professional medical care | 0.355949 |
| contracting malaria | 0.493517 |
| Page | 0.399529 |
| effective antimalarial drugs | 0.366575 |
| effective malaria vaccine | 0.505889 |
| antimalarial drugs chloroquine | 0.358928 |
| Plasmodium falciparum | 0.357673 |
| malaria parasite | 0.553795 |
| antimalarial drugs | 0.490421 |
| P. falciparum | 0.339014 |
| good antimalarial drugs | 0.359432 |
| malaria infection | 0.504473 |
| malaria drugs | 0.56295 |
| flu-like illness | 0.354 |
| area | 0.346392 |
| Malaria self-treatment | 0.476341 |
| countries | 0.346836 |
| microscopic malaria parasites | 0.537481 |
| Africa south | 0.345101 |
| effective malaria treatment | 0.491815 |
| malaria attacks | 0.473723 |
| P. ovale | 0.378287 |
| malaria parasites | 0.642919 |
|
| malaria treatment medicines | 0.488916 |
| antimalarial drug Malarone | 0.348517 |
| malaria causes | 0.516926 |
| United States | 0.508077 |
| malaria exists | 0.477573 |
| malaria | 0.906829 |
| malaria preventive drugs | 0.502806 |
| previous blood meal | 0.338326 |
| P. vivax | 0.369454 |
| No. Malaria | 0.503669 |
| solid malaria control | 0.49259 |
| transfusion-transmitted malaria | 0.479843 |
| effective malaria | 0.514094 |
| blood transfusion | 0.337891 |
| principal malaria mosquito | 0.496796 |
| malaria treatment medication | 0.489894 |
| disease | 0.365987 |
| breast milk | 0.35484 |
| malaria immunity | 0.493244 |
| people | 0.366376 |
| infected person | 0.346204 |
| health-care provider | 0.44702 |
| malaria transmission | 0.769011 |
| antimalarial drug | 0.397215 |
|
CLICK HERE |
| 8935 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Information Statement: Shingles - Vaccines - CDC |
Shingles Vaccine Information Statement |
| catch shingles | 0.662988 |
| Page | 0.398035 |
| body | 0.339541 |
| nearest hospital | 0.389115 |
| severe allergies | 0.455989 |
| severe allergic reaction | 0.799726 |
| chills | 0.323931 |
| shingles | 0.986961 |
| severe problems | 0.444549 |
| immune systems | 0.398266 |
| clinical trials | 0.397456 |
| post-herpetic neuralgia | 0.418626 |
| soreness | 0.321989 |
| fast heartbeat | 0.391152 |
| chickenpox vaccine | 0.621584 |
| shingles vaccine | 0.946526 |
| Herpes Zoster | 0.433627 |
| Vaccine Adverse Event | 0.567824 |
| Mild problems | 0.394756 |
| behavior changes | 0.389521 |
| VAERS website | 0.413817 |
| life-threatening allergic reaction | 0.521668 |
| person | 0.466403 |
| difficulty breathing | 0.386938 |
| shingles infection | 0.671841 |
|
| single dose | 0.397132 |
| United States | 0.39827 |
| upset stomach | 0.413971 |
| Varicella Zoster virus | 0.508922 |
| medical advice | 0.395413 |
| minor acute illness | 0.462086 |
| main symptom | 0.414519 |
| signs | 0.329271 |
| pneumonia | 0.319666 |
| state health department | 0.463891 |
| Current Edition Date | 0.502772 |
| younger people | 0.398072 |
| painful skin rash | 0.520499 |
| severe allergic reactions | 0.549191 |
| severe pain | 0.46282 |
| blisters | 0.322123 |
| severe acute illness | 0.523136 |
| doctor | 0.363546 |
| brain inflammation | 0.404548 |
| face | 0.333613 |
| antibiotic neomycin | 0.40386 |
| risk | 0.334663 |
| headache | 0.342084 |
| gelatin | 0.320053 |
|
CLICK HERE |
| 10825 |
Centers for Disease Control and Prevention |
Html |
en |
Health, United States, 2013 includes special section on prescription drugs |
CDC announces second imported case of Middle East Respiratory Syndrome (MERS) in the United States |
| key health measures | 0.461017 |
| insurance coverage | 0.382864 |
| high cholesterol | 0.404893 |
| commonly used classes | 0.470258 |
| Disease Control | 0.396567 |
| prescription drugs | 0.975827 |
| private sector. | 0.38116 |
| federal government | 0.378979 |
| commonly used prescription | 0.66662 |
| Americans | 0.334578 |
| cholesterol-lowering drug | 0.424065 |
| reproductive health | 0.39346 |
| health expenditures | 0.397515 |
| life expectancy | 0.384328 |
| medical visits | 0.388846 |
| statin drugs | 0.472277 |
| private sector | 0.39105 |
| prescription drugs. Key | 0.54256 |
| birth rates | 0.383239 |
| blood thinners | 0.391139 |
| Drug poisoning deaths | 0.453473 |
| health care utilization | 0.462962 |
| United States | 0.485772 |
| 37th annual report | 0.480251 |
| age group | 0.387238 |
|
| adults | 0.46668 |
| common prescription drugs | 0.653739 |
| kidney disease | 0.391421 |
| percent | 0.523518 |
| Cardiovascular agents | 0.403956 |
| federal health agencies | 0.490054 |
| Health Statistics. | 0.41248 |
| heart disease | 0.393165 |
| U.S. DEPARTMENT | 0.383604 |
| comprehensive report | 0.406267 |
| cardiovascular disease | 0.414622 |
| health risk behaviors | 0.463139 |
| cold symptoms | 0.390972 |
| health data | 0.412318 |
| retail prescription drugs | 0.582758 |
| cardiovascular agent | 0.485006 |
| opioid analgesics | 0.413377 |
| annual growth | 0.382546 |
| antidepressants | 0.341811 |
| special section | 0.396767 |
| high blood pressure | 0.467424 |
| Prevention’s National | 0.397877 |
| Human Services | 0.481474 |
| past decade | 0.387914 |
|
CLICK HERE |
| 10865 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Impact of Data Editing Methods on Estimates of Smoking Prevalence, Global Youth Tobacco Survey, 2007–2009 - CDC |
Accuracy of self-reported data may be improved by data editing, a mechanism to produce accurate information by excluding inconsistent data based on a set number of predetermined decision rules. We compared data editing methods in the Global Youth Tobacco Survey (GYTS) with other editing approaches and evaluated the effects of these on smoking prevalence estimates. |
| logic checks | 0.538825 |
| Data Edit ApproachDescription | 0.453315 |
| data | 0.903478 |
| inconsistent responses | 0.731199 |
| global approach | 0.567732 |
| GYTS data editing | 0.524597 |
| questions | 0.453202 |
| relative SE | 0.479013 |
| PreponderanceCurrent cigarette smoking | 0.461479 |
| weighted point estimates | 0.532833 |
| Disease Control | 0.482697 |
| Youth Tobacco Survey | 0.796816 |
| GYTS data | 0.728056 |
| preponderance approach | 0.740352 |
| GYTS data edits | 0.625406 |
| higher estimates | 0.603761 |
| current cigarette smoking | 0.461489 |
| estimates | 0.824971 |
| Global Tobacco Control | 0.51339 |
| data editing approaches | 0.613601 |
| cross-study comparability | 0.526908 |
| Herbst K. Data | 0.4625 |
| similar estimates | 0.544107 |
| data editing approach | 0.569839 |
| cigarette use status | 0.471339 |
|
| current cigarette | 0.520451 |
| preponderance approaches | 0.484919 |
| subsequent inconsistent responses | 0.461771 |
| 2-stage cluster sample | 0.574311 |
| Self-reported cigarette smoking | 0.489861 |
| cigarette smoking status | 0.796421 |
| gatekeeper approaches | 0.590335 |
| decision rules | 0.511736 |
| sex groups | 0.456627 |
| data editing method | 0.60671 |
| cigarette smoking | 0.808719 |
| GYTS | 0.76104 |
| Saudi Arabia | 0.728458 |
| self-administered school-based survey | 0.452659 |
| smoking prevalence estimates | 0.573688 |
| Tobacco Control Branch | 0.514881 |
| data editing methods | 0.692673 |
| Global Youth Tobacco | 0.65752 |
| inconsistent data | 0.623082 |
| GYTS estimates | 0.5431 |
| point estimates | 0.623501 |
| Chronic Disease Prevention | 0.516448 |
| overall estimates | 0.464747 |
| data editing | 0.874155 |
|
CLICK HERE |
| 12869 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Diet Quality and History of Gestational Diabetes Mellitus Among Childbearing Women, United States, 2007"2010 - CDC |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| total HEI-2010 diet | 0.478316 |
| dietary guidelines | 0.487935 |
| component diet quality | 0.527397 |
| diet quality score | 0.607412 |
| type | 0.472232 |
| chronic disease risk | 0.471897 |
| GDM | 0.753096 |
| previous borderline GDM | 0.559862 |
| overall diet quality | 0.776915 |
| Disease Control | 0.473614 |
| overall average diet | 0.471683 |
| smoking status | 0.481597 |
| Introduction
Women | 0.467607 |
| Nutrition Examination Survey | 0.514974 |
| national health | 0.492312 |
| history | 0.630027 |
| gestational diabetes mellitus | 0.592789 |
| total HEI-2010 score | 0.474853 |
| childbearing women | 0.489815 |
| GDM diagnosis | 0.533982 |
| linear regression models | 0.506958 |
| total diet quality | 0.492787 |
| women | 0.740171 |
| high school graduate | 0.466918 |
|
| United States | 0.5296 |
| poorer diet quality | 0.494736 |
| maternal diet quality | 0.484369 |
| GDM data | 0.535315 |
| lower diet quality | 0.504048 |
| sugar diabetes | 0.483849 |
| Healthy Eating Index | 0.475926 |
| recent live infant | 0.479031 |
| average diet quality | 0.505455 |
| recent gestational diabetes | 0.479796 |
| Massachusetts Medical School | 0.526025 |
| borderline diabetes | 0.482732 |
| Diabetes Care | 0.478153 |
| health | 0.521304 |
| HEI-2010 diet quality | 0.519662 |
| poor diet quality | 0.574225 |
| 24-hour dietary recall | 0.47941 |
| physical activity | 0.472994 |
| current diet quality | 0.502472 |
| MyPyramid Equivalents Database | 0.467061 |
| diet quality | 0.943228 |
| American Diabetes Association | 0.480915 |
| diabetes | 0.612957 |
| good-quality overall diet | 0.474945 |
|
CLICK HERE |
| 13147 |
Centers for Disease Control and Prevention |
Html |
en |
Sudden Unexpected Infant Death (SUID) and SuddenInfant Death Syndrome (SIDS) - SIDS and SUID - ReproductiveHealth |
null |
| complete autopsy | 0.571558 |
| different ways | 0.547573 |
| SUID cases | 0.538322 |
| SIDS | 0.722993 |
| data | 0.427581 |
| United States | 0.697187 |
| Reproductive Health | 0.544661 |
| sudden unexpected infant | 0.927912 |
| soft bedding—for example | 0.673948 |
| death scene | 0.669256 |
| strangulation | 0.428508 |
| Unknown cause | 0.581276 |
| sudden death | 0.729196 |
| syndrome | 0.430569 |
| review | 0.429987 |
| CDC resources | 0.553607 |
| examination | 0.428392 |
| jurisdictions | 0.46533 |
| nose | 0.430321 |
| circumstances | 0.46444 |
|
| types | 0.432457 |
| clinical history | 0.563574 |
| infants | 0.476151 |
| overlay | 0.433456 |
| sleep-related infant deaths | 0.817366 |
| strategies | 0.427504 |
| infant deaths | 0.84344 |
| future deaths | 0.582817 |
| people | 0.427119 |
| SUIDs | 0.461642 |
| SUID trends | 0.541441 |
| thorough investigation | 0.700179 |
| mouth | 0.429668 |
| tests | 0.427698 |
| matters | 0.427138 |
| Accidental suffocation | 0.642777 |
| activities | 0.427213 |
| pillow | 0.43146 |
| parts | 0.42879 |
| age | 0.465276 |
|
CLICK HERE |
| 14418 |
Centers for Disease Control and Prevention |
Html |
en |
CDC study: Former NFL players not at increased risk of suicide | CDC Online Newsroom |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| suicide risk | 0.373273 |
| CDC’s National | 0.306158 |
| current discussion | 0.286069 |
| Disease Control | 0.303276 |
| NFL speed-position players | 0.416279 |
| suicide rate | 0.38098 |
| suicide deaths | 0.467323 |
| scientific literature | 0.294009 |
| NIOSH research | 0.32933 |
| greater risk | 0.309312 |
| new study | 0.305094 |
| NIOSH | 0.379827 |
| general U.S. population | 0.91666 |
| American Journal | 0.300709 |
| age-matched people | 0.297007 |
| NFL group | 0.331602 |
| Fifty-eight percent | 0.304944 |
| offensive linemen positions | 0.377982 |
| non-speed-position players | 0.307524 |
| professional football players | 0.52614 |
| Field Studies | 0.29142 |
| previous information | 0.290916 |
| NIOSH researchers | 0.347309 |
| neurodegenerative disease | 0.283164 |
| NFL Players Association | 0.40304 |
|
| general population | 0.467717 |
| head injury | 0.290416 |
| suicide death rate | 0.571776 |
| Occupational Safety | 0.2986 |
| Sports Medicine | 0.303366 |
| particular cohort | 0.295213 |
| heart disease | 0.285895 |
| different positions | 0.296986 |
| Hazard Evaluations | 0.290172 |
| white players | 0.307521 |
| higher risk | 0.425173 |
| different risks | 0.286271 |
| Douglas Trout | 0.287436 |
| National Football League | 0.3935 |
| nfl players | 0.59444 |
| black players | 0.309753 |
| non-speed positions | 0.298882 |
| latest study | 0.286553 |
| intentional self-harm | 0.292039 |
| wide receiver | 0.290584 |
| speed positions | 0.299176 |
| football players | 0.613664 |
| Deputy Director | 0.294234 |
| comparable gender/race/age sector | 0.371865 |
|
CLICK HERE |